On Nov. 5, 2025, dedicated volunteers from across the country joined us in Washington, DC, bringing their passion, expertise, and personal stories to the heart of our nation’s capital. Together, they met with numerous congressional offices to share how federal investment in cancer...
SITC’s 2025 Capitol Hill Visits have officially concluded after engaging with over 25 congressional offices! During these meetings, SITC members passionately advocated for the inclusion of SITC’s FY26 appropriations language, emphasizing the need for utilizing novel technologies to advance the...
SITC is pleased to announce the kickoff of SITC’s 2025 in person Capitol Hill Visits! Over the last few months SITC members have been meeting virtually with congressional offices all across the country to advocate for inclusion of SITC’s FY26 appropriations language aimed at utilizing novel...
SITC is pleased to announce the kickoff of SITC’s 2025 Capitol Hill Visits! SITC members are meeting with congressional offices to advocate for inclusion of SITC’s FY26 appropriations language aimed at utilizing novel technologies to advance the field’s understanding of the tumor...
SITC has recently signed on to a letter from the Leukemia Lymphoma Society advocating congress to pass the Accelerating Kids Access to Care Act (AKACA). SITC joined 230 other organizations in supporting this important piece of legislation. More information on the bill as well as the final letter...
This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients around the globe and in resource limited settings. It provided a forum for physicians to discuss their experience assessing different criteria, as well as the solutions that were implemented to...
This webinar on October 16th examined the importance of monitoring response to cancer immunotherapy, with a specific focus on image evaluation and predictive AI. The program featured discussions from leading scientists and radiologists in the field of IO on how feasible these tools are in a...
Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to identify the next generation of potential life-saving treatments. However, it can be difficult to design trials that will be able to efficiently enroll patients, especially in the field of...
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent resistance and identify alternative therapeutic uses. Imaging-based AI that can closely analyze drug-specific structures and interactions are being developed to help expedite discoveries...
SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies; Guidance for Industry - Draft Guidance". SITC was pleased to see FDA incorporate feedback and topics that have stemmed from recent...